DBV Technologies (DBVT) Operating Leases (2019 - 2026)

DBV Technologies (DBVT) posted quarterly Operating Leases of $7.7 million for Q2 2026, little changed year-on-year from $7.7 million in Q2 2025, and up 26.23% on a QoQ basis from $6.1 million in Q1 2026.

DBV Technologies (DBVT) Operating Leases (2019 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Operating Leases for 8 consecutive years, with $7.7 million the latest figure, recorded in Q2 2026.

  • Quarterly Operating Leases changed 0.06% year-over-year to $7.7 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $7.7 million (changed 0.06% YoY) and the FY2025 annual result came in at $6.5 million, down 6.49% from the prior year.
  • Operating Leases grew to $7.7 million in Q2 2026 per DBVT's latest filing, from $6.1 million in the prior quarter.
  • Over the last five years, Operating Leases for DBVT reached as high as $7.7 million in Q2 2026 and fell as low as $1.6 million in Q3 2023.
  • A 5-year average of $5.4 million and a median of $6.3 million in 2025 frame the typical range for Operating Leases.
  • Annual changes were most pronounced in 2022 — Operating Leases tumbled 70.24% — and 2024, when it surged 358.66%.
  • Year by year, Operating Leases stood at $3.0 million in 2022, then surged by 87.65% to $5.7 million in 2023, then grew by 22.61% to $7.0 million in 2024, then dropped by 6.49% to $6.5 million in 2025, then increased by 18.46% to $7.7 million in 2026.
  • According to Business Quant data, Operating Leases over the past three periods registered $7.7 million, $6.1 million, and $6.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 DBV Technologies 267.50 Mn 92.60 Mn -

Historic Data

Download Data
DateValue
Jun 30, 2026 7.70 Mn
Mar 31, 2026 6.10 Mn
Dec 31, 2025 6.50 Mn
Sep 30, 2025 7.69 Mn
Jun 30, 2025 7.70 Mn
Mar 31, 2025 7.23 Mn
Dec 31, 2024 6.95 Mn
Sep 30, 2024 7.41 Mn
Jun 30, 2024 7.16 Mn
Mar 31, 2024 7.03 Mn
Dec 31, 2023 5.67 Mn
Sep 30, 2023 1.62 Mn
Jun 30, 2023 2.13 Mn
Mar 31, 2023 2.60 Mn
Dec 31, 2022 3.02 Mn
Sep 30, 2022 2.80 Mn
Jun 30, 2022 3.94 Mn
Mar 31, 2022 4.30 Mn
Dec 31, 2021 10.15 Mn
Sep 30, 2021 8.30 Mn